GMP BIO Co., LTD.   Report issue

For profit Phase 2
Founded: Gwangju Korea, Republic of (2000)

Organization Overview

First Clinical Trial
2007
NCT03973099
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Director | GMP BIO Co., LTD.